Global Diabetes Testing System Market Research Report 2025

Publication ID:

PB502254197

Publication Date:

February 13, 2025

Pages:

Publisher:

MRRPB5

Countries:

Global [1]

USD 2,900.00

Medical Devices [2]

Pharma & Healthcare [3]

Description:

The global market for Diabetes Testing System was valued at US$ 3878 million in the year 2024 and is projected to reach a revised size of US$ 6985 million by 2031, growing at a CAGR of 8.9% during the forecast period.
Diabetes Testing Systems are the systems used at home or health care settings for monitoring the blood glucose levels in diabetic patients. Testing blood glucose level is the best way to understand diabetes and how different foods, medications, and other activities affect diabetes.
The market for diabetes testing systems has been witnessing significant growth in recent years due to the increasing prevalence of diabetes and the growing awareness about the importance of regular monitoring of blood glucose levels. According to the International Diabetes Federation, the number of people with diabetes is projected to reach 700 million by 2045.
The market is driven by factors such as the rising geriatric population, sedentary lifestyles, unhealthy dietary habits, and the increasing prevalence of obesity. Additionally, advancements in technology have led to the development of innovative glucose monitoring systems that offer better accuracy, convenience, and ease of use.
Key players in the global diabetes testing system market include Abbott Laboratories, Roche Diagnostics, Dexcom, Inc., Medtronic plc, Ascensia Diabetes Care Holdings AG, Johnson & Johnson, and Becton, Dickinson and Company, among others. These companies invest in research and development activities to introduce new and advanced diabetes testing systems in the market.
The market is segmented based on product type, which includes self-monitoring blood glucose systems, continuous glucose monitoring systems, and others. Geographically, North America holds a significant share in the market, followed by Europe and the Asia Pacific region.
The global diabetes testing system market is anticipated to witness continued growth in the coming years, driven by the increasing prevalence of diabetes and the continuous efforts of market players to develop and commercialize innovative testing systems.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Diabetes Testing System, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Diabetes Testing System.
The Diabetes Testing System market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Diabetes Testing System market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Diabetes Testing System manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
By Company
Roche Holding AG
Abbott Laboratories
Sanofi S.A.
ACON Laboratories
Nova Biomedical
Nipro Corporation
Braun Holding GmbH
DexCom
Medtronic Plc
ARKRAY
LifeScan
Ascensia Diabetes Care
Segment by Type
Self-Monitoring Diabetes Testing Systems
Continuous Diabetes Testing Systems
Others
Segment by Application
Home Care
Hospitals
Clinics
Others
Consumption by Region
North America
U.S.
Canada
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Europe
Germany
France
U.K.
Italy
Russia
Latin America
Mexico
Brazil
Argentina
Middle East and Africa
Turkey
Saudi Arabia
U.A.E
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Diabetes Testing System manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Diabetes Testing System in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.鈥�

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Diabetes Testing System Market Overview
1.1 Product Definition
1.2 Diabetes Testing System by Type
1.2.1 Global Diabetes Testing System Market Value Comparison by Type (2024 VS 2031)
1.2.2 Self-Monitoring Diabetes Testing Systems
1.2.3 Continuous Diabetes Testing Systems
1.2.4 Others
1.3 Diabetes Testing System by Application
1.3.1 Global Diabetes Testing System Market Value by Application (2024 VS 2031)
1.3.2 Home Care
1.3.3 Hospitals
1.3.4 Clinics
1.3.5 Others
1.4 Global Diabetes Testing System Market Size Estimates and Forecasts
1.4.1 Global Diabetes Testing System Revenue 2020-2031
1.4.2 Global Diabetes Testing System Sales 2020-2031
1.4.3 Global Diabetes Testing System Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Diabetes Testing System Market Competition by Manufacturers
2.1 Global Diabetes Testing System Sales Market Share by Manufacturers (2020-2025)
2.2 Global Diabetes Testing System Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Diabetes Testing System Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Diabetes Testing System, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Diabetes Testing System, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Diabetes Testing System, Product Type & Application
2.7 Global Key Manufacturers of Diabetes Testing System, Date of Enter into This Industry
2.8 Global Diabetes Testing System Market Competitive Situation and Trends
2.8.1 Global Diabetes Testing System Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Diabetes Testing System Players Market Share by Revenue
2.8.3 Global Diabetes Testing System Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Diabetes Testing System Market Scenario by Region
3.1 Global Diabetes Testing System Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Diabetes Testing System Sales by Region: 2020-2031
3.2.1 Global Diabetes Testing System Sales by Region: 2020-2025
3.2.2 Global Diabetes Testing System Sales by Region: 2026-2031
3.3 Global Diabetes Testing System Revenue by Region: 2020-2031
3.3.1 Global Diabetes Testing System Revenue by Region: 2020-2025
3.3.2 Global Diabetes Testing System Revenue by Region: 2026-2031
3.4 North America Diabetes Testing System Market Facts & Figures by Country
3.4.1 North America Diabetes Testing System Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Diabetes Testing System Sales by Country (2020-2031)
3.4.3 North America Diabetes Testing System Revenue by Country (2020-2031)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Diabetes Testing System Market Facts & Figures by Country
3.5.1 Europe Diabetes Testing System Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Diabetes Testing System Sales by Country (2020-2031)
3.5.3 Europe Diabetes Testing System Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Diabetes Testing System Market Facts & Figures by Region
3.6.1 Asia Pacific Diabetes Testing System Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Diabetes Testing System Sales by Region (2020-2031)
3.6.3 Asia Pacific Diabetes Testing System Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Diabetes Testing System Market Facts & Figures by Country
3.7.1 Latin America Diabetes Testing System Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Diabetes Testing System Sales by Country (2020-2031)
3.7.3 Latin America Diabetes Testing System Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Diabetes Testing System Market Facts & Figures by Country
3.8.1 Middle East and Africa Diabetes Testing System Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Diabetes Testing System Sales by Country (2020-2031)
3.8.3 Middle East and Africa Diabetes Testing System Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global Diabetes Testing System Sales by Type (2020-2031)
4.1.1 Global Diabetes Testing System Sales by Type (2020-2025)
4.1.2 Global Diabetes Testing System Sales by Type (2026-2031)
4.1.3 Global Diabetes Testing System Sales Market Share by Type (2020-2031)
4.2 Global Diabetes Testing System Revenue by Type (2020-2031)
4.2.1 Global Diabetes Testing System Revenue by Type (2020-2025)
4.2.2 Global Diabetes Testing System Revenue by Type (2026-2031)
4.2.3 Global Diabetes Testing System Revenue Market Share by Type (2020-2031)
4.3 Global Diabetes Testing System Price by Type (2020-2031)
5 Segment by Application
5.1 Global Diabetes Testing System Sales by Application (2020-2031)
5.1.1 Global Diabetes Testing System Sales by Application (2020-2025)
5.1.2 Global Diabetes Testing System Sales by Application (2026-2031)
5.1.3 Global Diabetes Testing System Sales Market Share by Application (2020-2031)
5.2 Global Diabetes Testing System Revenue by Application (2020-2031)
5.2.1 Global Diabetes Testing System Revenue by Application (2020-2025)
5.2.2 Global Diabetes Testing System Revenue by Application (2026-2031)
5.2.3 Global Diabetes Testing System Revenue Market Share by Application (2020-2031)
5.3 Global Diabetes Testing System Price by Application (2020-2031)
6 Key Companies Profiled
6.1 Roche Holding AG
6.1.1 Roche Holding AG Company Information
6.1.2 Roche Holding AG Description and Business Overview
6.1.3 Roche Holding AG Diabetes Testing System Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Roche Holding AG Diabetes Testing System Product Portfolio
6.1.5 Roche Holding AG Recent Developments/Updates
6.2 Abbott Laboratories
6.2.1 Abbott Laboratories Company Information
6.2.2 Abbott Laboratories Description and Business Overview
6.2.3 Abbott Laboratories Diabetes Testing System Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Abbott Laboratories Diabetes Testing System Product Portfolio
6.2.5 Abbott Laboratories Recent Developments/Updates
6.3 Sanofi S.A.
6.3.1 Sanofi S.A. Company Information
6.3.2 Sanofi S.A. Description and Business Overview
6.3.3 Sanofi S.A. Diabetes Testing System Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Sanofi S.A. Diabetes Testing System Product Portfolio
6.3.5 Sanofi S.A. Recent Developments/Updates
6.4 ACON Laboratories
6.4.1 ACON Laboratories Company Information
6.4.2 ACON Laboratories Description and Business Overview
6.4.3 ACON Laboratories Diabetes Testing System Sales, Revenue and Gross Margin (2020-2025)
6.4.4 ACON Laboratories Diabetes Testing System Product Portfolio
6.4.5 ACON Laboratories Recent Developments/Updates
6.5 Nova Biomedical
6.5.1 Nova Biomedical Company Information
6.5.2 Nova Biomedical Description and Business Overview
6.5.3 Nova Biomedical Diabetes Testing System Sales, Revenue and Gross Margin (2020-2025)
6.5.4 Nova Biomedical Diabetes Testing System Product Portfolio
6.5.5 Nova Biomedical Recent Developments/Updates
6.6 Nipro Corporation
6.6.1 Nipro Corporation Company Information
6.6.2 Nipro Corporation Description and Business Overview
6.6.3 Nipro Corporation Diabetes Testing System Sales, Revenue and Gross Margin (2020-2025)
6.6.4 Nipro Corporation Diabetes Testing System Product Portfolio
6.6.5 Nipro Corporation Recent Developments/Updates
6.7 Braun Holding GmbH
6.7.1 Braun Holding GmbH Company Information
6.7.2 Braun Holding GmbH Description and Business Overview
6.7.3 Braun Holding GmbH Diabetes Testing System Sales, Revenue and Gross Margin (2020-2025)
6.7.4 Braun Holding GmbH Diabetes Testing System Product Portfolio
6.7.5 Braun Holding GmbH Recent Developments/Updates
6.8 DexCom
6.8.1 DexCom Company Information
6.8.2 DexCom Description and Business Overview
6.8.3 DexCom Diabetes Testing System Sales, Revenue and Gross Margin (2020-2025)
6.8.4 DexCom Diabetes Testing System Product Portfolio
6.8.5 DexCom Recent Developments/Updates
6.9 Medtronic Plc
6.9.1 Medtronic Plc Company Information
6.9.2 Medtronic Plc Description and Business Overview
6.9.3 Medtronic Plc Diabetes Testing System Sales, Revenue and Gross Margin (2020-2025)
6.9.4 Medtronic Plc Diabetes Testing System Product Portfolio
6.9.5 Medtronic Plc Recent Developments/Updates
6.10 ARKRAY
6.10.1 ARKRAY Company Information
6.10.2 ARKRAY Description and Business Overview
6.10.3 ARKRAY Diabetes Testing System Sales, Revenue and Gross Margin (2020-2025)
6.10.4 ARKRAY Diabetes Testing System Product Portfolio
6.10.5 ARKRAY Recent Developments/Updates
6.11 LifeScan
6.11.1 LifeScan Company Information
6.11.2 LifeScan Description and Business Overview
6.11.3 LifeScan Diabetes Testing System Sales, Revenue and Gross Margin (2020-2025)
6.11.4 LifeScan Diabetes Testing System Product Portfolio
6.11.5 LifeScan Recent Developments/Updates
6.12 Ascensia Diabetes Care
6.12.1 Ascensia Diabetes Care Company Information
6.12.2 Ascensia Diabetes Care Description and Business Overview
6.12.3 Ascensia Diabetes Care Diabetes Testing System Sales, Revenue and Gross Margin (2020-2025)
6.12.4 Ascensia Diabetes Care Diabetes Testing System Product Portfolio
6.12.5 Ascensia Diabetes Care Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Diabetes Testing System Industry Chain Analysis
7.2 Diabetes Testing System Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Diabetes Testing System Production Mode & Process Analysis
7.4 Diabetes Testing System Sales and Marketing
7.4.1 Diabetes Testing System Sales Channels
7.4.2 Diabetes Testing System Distributors
7.5 Diabetes Testing System Customer Analysis
8 Diabetes Testing System Market Dynamics
8.1 Diabetes Testing System Industry Trends
8.2 Diabetes Testing System Market Drivers
8.3 Diabetes Testing System Market Challenges
8.4 Diabetes Testing System Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer

Companies Mentioned:

Roche Holding AG
Abbott Laboratories
Sanofi S.A.
ACON Laboratories
Nova Biomedical
Nipro Corporation
Braun Holding GmbH
DexCom
Medtronic Plc
ARKRAY
LifeScan
Ascensia Diabetes Care

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.

91制片厂